Spot Urinary Sodium as a Biomarker of Diuretic Response in Acute Heart Failure

Nestor Oliva-Damaso, Julio Nuñez, Maria Jose Soler, Nestor Oliva-Damaso, Julio Nuñez, Maria Jose Soler

No abstract available

Keywords: biomarkers; diuretic response; heart failure; urine sodium.

Figures

Figure 1. Guided diuretic therapy according to…
Figure 1. Guided diuretic therapy according to early post‐diuretic spot urinary sodium in acute heart failure.
In AHF, the kidneys shows higher avidity of sodium reabsorption, and consequently low urinary sodium is frequently present and associated with more severe disease. Excluding cirrhotic, in fluid overload patients with AHF, a spot UNa

References

    1. Weber KT. Aldosterone in congestive heart failure. N Engl J Med. 2001;345:1689–1697. doi: 10.1056/NEJMra000050
    1. Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure. J Am Coll Cardiol. 2020;75:1178–1195. doi: 10.1016/j.jacc.2019.12.059
    1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–3726. doi: 10.1093/eurheartj/ehab368
    1. Khorramshahi Bayat M, Ngo L, Mulligan A, Chan W, McKenzie S, Hay K, Ranasinghe I. The association between urinary sodium concentration (UNa) and outcomes of acute heart failure: a systematic review and meta‐analysis. Eur Heart J. 2022;8:709–721. doi: 10.1093/ehjqcco/qcac007
    1. Averbuch T, Damman K, Van Spall HGC. Urinary sodium: worth its salt? Eur Heart J Qual Care Clin Outcomes. 2022;8:701–702. doi: 10.1093/ehjqcco/qcac015
    1. Damman K, Ter Maaten JM, Coster JE, Krikken JA, van Deursen VM, Krijnen HK, Hofman M, Nieuwland W, van Veldhuisen DJ, Voors AA, et al. Clinical importance of urinary sodium excretion in acute heart failure. Eur J Heart Fail. 2020;22:1438–1447. doi: 10.1002/ejhf.1753
    1. Martens P, Chen HH, Verbrugge FH, Testani JT, Mullens W, Tang WHW. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion. Eur J Heart Fail. 2022;24:1978–1987. doi: 10.1002/ejhf.2662
    1. Chatur S, Lakdawala NK, Cunningham JW. Random admission urinary sodium for diuretic response: promise in pragmatism? Eur J Heart Fail. 2022;24:1988–1989. doi: 10.1002/ejhf.2704
    1. de la Espriella R, Núñez E, Llàcer P, García‐Blas S, Ventura S, Núñez JM, Sánchez R, Fácila L, Vaquer JM, Bodí V, et al. Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction. Rev Esp Card (Engl Ed). 2021;74:616–623. doi: 10.1016/j.rec.2020.06.004
    1. Dauw J, Lelonek M, Zegri‐Reiriz I, Paredes‐Paucar CP, Zara C, George V, Cobo‐Marcos M, Knappe D, Shchekochikhin D, Lekhakul A, et al. Rationale and design of the efficacy of a standardized diuretic protocol in acute heart failure study. ESC Heart Failure. 2021;8:4685–4692. doi: 10.1002/ehf2.13666
    1. ter Maaten JM, Beldhuis IE, van der Meer P, Krikken JA, Coster JE, Nieuwland W, van Veldhuisen DJ, Voors AA, Damman K. Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial. Eur J Heart Fail. 2022;24:385–392. doi: 10.1002/ejhf.2385
    1. Ellison DH, Felker GM. Diuretic treatment in heart failure. N Engl J Med. 2017;377:1964–1975. doi: 10.1056/NEJMra1703100
    1. Cobo Marcos M, de la Espriella R, Gayán Ordás J, Llàcer P, Pomares A, Fort A, Ponz de Antonio I, Méndez A, Blázquez‐Bermejo Z, Caravaca Pérez P, et al. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry. Rev Esp Cardiol (Engl Ed). 2023;S1885–5857(23)00140‐8. doi: 10.1016/j.rec.2023.05.003
    1. Danovitch GM, Bourgoignie J, Bricker NS. Reversibility of the “salt‐losing” tendency of chronic renal failure. N Engl J Med. 1977;296:14–19. doi: 10.1056/NEJM197701062960104
    1. Oliva‐Damaso N, Lendinez A, Rivas‐Ruiz F, Lopez F, Castilla MDM, Oliva‐Damaso E, Ramirez A, Payan J. Elevated urinary alpha‐1 microglobulin levels are associated with decreased survival among chronic kidney disease patients: a real‐world population study. J Nephrol. 2022;36:285–288. doi: 10.1007/s40620-022-01499-3
    1. Okusa M, Chopra T. Fractional excretion of sodium, urea, and other molecules in acute kidney injury. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc; 2023. Accessed August 5, 2023.
    1. Rao VS, Ivey‐Miranda JB, Cox ZL, Riello R, Griffin M, Fleming J, Soucier R, Sangkachand P, O'Brien M, LoRusso F, et al. Natriuretic equation to predict loop diuretic response in patients with heart failure. J Am Coll Cardiol. 2021;77:695–708. doi: 10.1016/j.jacc.2020.12.022
    1. Kazory A. Combination diuretic therapy to counter renal sodium avidity in acute heart failure: trials and tribulations. CJASN. [published online April 27, 2023]. doi: 10.2215/CJN.0000000000000188
    1. Nadim MK, Garcia‐Tsao G. Acute kidney injury in patients with cirrhosis. N Engl J Med. 2023;388:733–745. doi: 10.1056/NEJMra2215289
    1. Meekers E, Mullens W. Spot urinary sodium measurements: the future direction of the treatment and follow‐up of patients with heart failure. Curr Heart Fail Rep. 2023;20:88–100. doi: 10.1007/s11897-023-00591-4

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться